Nothing Special   »   [go: up one dir, main page]

ES2131482A1 - Formulacion acuosa de bambuterol. - Google Patents

Formulacion acuosa de bambuterol.

Info

Publication number
ES2131482A1
ES2131482A1 ES09702568A ES9702568A ES2131482A1 ES 2131482 A1 ES2131482 A1 ES 2131482A1 ES 09702568 A ES09702568 A ES 09702568A ES 9702568 A ES9702568 A ES 9702568A ES 2131482 A1 ES2131482 A1 ES 2131482A1
Authority
ES
Spain
Prior art keywords
bambuterol
aqueous formulation
pharmaceutically acceptable
acceptable salts
aqueous formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09702568A
Other languages
English (en)
Other versions
ES2131482B1 (es
Inventor
Staffan Annefors
Carl-Axel Bauer
Hans Nilsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra AB filed Critical Astra AB
Publication of ES2131482A1 publication Critical patent/ES2131482A1/es
Application granted granted Critical
Publication of ES2131482B1 publication Critical patent/ES2131482B1/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Formulación acuosa de bambuterol. Esta formulación incluye, además de bambuterol como tal o en forma de una de sus sales farmacéuticamente aceptables, preferiblemente su sal hidrocloruro, uno o más ingredientes adicionales seleccionados entre agentes de tamponamiento, edulcorantes, conservantes y saborizantes. La invención es aplicable a la preparación de medicamentos pediátricos, especialmente broncodilatadores.
ES009702568A 1996-12-20 1997-12-10 Formulacion acuosa de bambuterol. Expired - Lifetime ES2131482B1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9604752A SE9604752D0 (sv) 1996-12-20 1996-12-20 Formulation and use

Publications (2)

Publication Number Publication Date
ES2131482A1 true ES2131482A1 (es) 1999-07-16
ES2131482B1 ES2131482B1 (es) 2000-03-01

Family

ID=20405108

Family Applications (1)

Application Number Title Priority Date Filing Date
ES009702568A Expired - Lifetime ES2131482B1 (es) 1996-12-20 1997-12-10 Formulacion acuosa de bambuterol.

Country Status (24)

Country Link
US (1) US6075048A (es)
EP (1) EP0921795A1 (es)
JP (1) JP2001501225A (es)
KR (1) KR19990082274A (es)
CN (1) CN1210464A (es)
AU (1) AU7871398A (es)
BE (1) BE1011395A5 (es)
BR (1) BR9707574A (es)
CA (1) CA2243085A1 (es)
CZ (1) CZ243898A3 (es)
ES (1) ES2131482B1 (es)
FR (1) FR2757398B1 (es)
GR (1) GR1003207B (es)
HU (1) HUP9901792A3 (es)
ID (1) ID23693A (es)
IE (1) IE970899A1 (es)
IL (1) IL125535A0 (es)
NL (1) NL1007839C2 (es)
NO (1) NO983556L (es)
PL (1) PL328334A1 (es)
SE (1) SE9604752D0 (es)
TR (1) TR199801500T1 (es)
WO (1) WO1998027981A1 (es)
ZA (1) ZA9711047B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9604752D0 (sv) * 1996-12-20 1996-12-20 Astra Ab Formulation and use
SE9903995D0 (sv) * 1999-11-03 1999-11-03 Astra Ab New combination
WO2006081986A1 (en) * 2005-02-07 2006-08-10 F.Hoffmann-La Roche Ag Bambuterol and integrin inhibitor combination
CN104784106A (zh) * 2014-01-17 2015-07-22 南京瑞尔医药有限公司 一种盐酸班布特罗口服溶液的制备方法
CN104784108A (zh) * 2014-01-17 2015-07-22 南京瑞尔医药有限公司 一种盐酸班布特罗口服溶液组合物
CN110898003A (zh) * 2019-12-09 2020-03-24 岳阳新华达制药有限公司 一种新型盐酸班布特罗口服溶液及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043807A2 (en) * 1980-07-09 1982-01-13 Aktiebolaget Draco 1-(Dihydroxyphenyl)-2-amino-ethanol derivatives; preparation, compositions and intermediates
US4499108A (en) * 1983-06-08 1985-02-12 Schering Corporation Stable pleasant-tasting albuterol sulfate pharmaceutical formulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086363A (en) * 1977-03-16 1978-04-25 Usv Pharmaceutical Corporation Treatment of asthma
GB9107196D0 (en) * 1991-04-05 1991-05-22 Sandoz Ag Improvements in or relating to organic compounds
GB2289842B (en) * 1991-04-05 1996-01-31 Sepracor Inc Improved use of ß2 bronchodilator drugs
SE9604752D0 (sv) * 1996-12-20 1996-12-20 Astra Ab Formulation and use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043807A2 (en) * 1980-07-09 1982-01-13 Aktiebolaget Draco 1-(Dihydroxyphenyl)-2-amino-ethanol derivatives; preparation, compositions and intermediates
US4499108A (en) * 1983-06-08 1985-02-12 Schering Corporation Stable pleasant-tasting albuterol sulfate pharmaceutical formulations

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CLEMMENSEN et al.: Bambuterol: clinical effects of three doses of bambuterol once daily in asthmatic patients. Allergy, 1988, Vol. 43, paginas 573-576 *
Mc. DONALD, C.F. et al.: Comparison of oral bambuterol and terbutaline in elderly patients with chronic reversible airflow obstruction. Journal of asthma, 1997, Vol. 34, no 1, paginas 53-59 *

Also Published As

Publication number Publication date
ZA9711047B (en) 1998-06-22
GR1003207B (el) 1999-09-14
NL1007839A1 (nl) 1998-06-23
HUP9901792A3 (en) 2000-04-28
FR2757398B1 (fr) 2000-09-01
ES2131482B1 (es) 2000-03-01
EP0921795A1 (en) 1999-06-16
NO983556D0 (no) 1998-08-03
TR199801500T1 (xx) 1999-02-22
CZ243898A3 (cs) 1998-11-11
IE970899A1 (en) 1998-10-07
JP2001501225A (ja) 2001-01-30
FR2757398A1 (fr) 1998-06-26
HUP9901792A2 (hu) 1999-10-28
NO983556L (no) 1998-08-03
CA2243085A1 (en) 1998-07-02
GR970100486A (el) 1998-08-31
ID23693A (id) 2000-05-11
WO1998027981A1 (en) 1998-07-02
AU7871398A (en) 1998-07-17
BR9707574A (pt) 1999-07-27
KR19990082274A (ko) 1999-11-25
BE1011395A5 (fr) 1999-08-03
SE9604752D0 (sv) 1996-12-20
NL1007839C2 (nl) 1998-08-31
US6075048A (en) 2000-06-13
IL125535A0 (en) 1999-03-12
PL328334A1 (en) 1999-01-18
CN1210464A (zh) 1999-03-10

Similar Documents

Publication Publication Date Title
WO1995017156A3 (en) Ethanol substitutes
CA2180816A1 (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
CA2193337A1 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
EP1172114A3 (en) Stable concentrated insulin preparations for pulmonary delivery
EP0995434A3 (en) Medicinal aerosol formulations
HUP9904051A3 (en) 4-hetaroylpyrazol derivatives, preparation and use thereof as herbicides
HUP0101461A3 (en) Novel pyridazine derivatives and drugs containing the same as the active ingredient
MXPA97002401A (es) Agente antiinflamatorio para uso externo.
AU1392900A (en) 2,5-diazabicyclo(2.2.1)heptane derivatives, their preparation and therapeutic uses
ITRM920412A1 (it) Eteroprostanoidi, procedimento per la loro preparazione e loro impiego terapeutico.
AU650484B2 (en) Isoxazole compound, pharmaceutically acceptable salt thereof, and medicinal use thereof
HUP9904109A2 (hu) Külsőleg használandó helyi érzéstelenítő
AU2001264042A1 (en) 1,4-diazabicyclo(3.2.2)nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof
AU2001264044A1 (en) 1,4-diazabicyclo(3.2.2)nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof
AU2001289606A1 (en) Dry powder formulation comprising racecadotril
WO1997028104A3 (de) Puffersysteme zur stabilisierung pharmazeutischer zubereitungen
ES2131482A1 (es) Formulacion acuosa de bambuterol.
GB9905663D0 (en) Iodine preparation composition
HUP9903649A3 (en) Taxane derivatives, the preparation thereof and medical formulations containing them
ZA978772B (en) N-(2-benzothiazolyl)-1-piperidineethanamine derivatives, their preparation and their use in therapy.
HUP0104238A3 (en) Benzoxazole derivatives and drugs containing the same as the active ingredient and their use
AU4062995A (en) 1-oxo-2-(phenylsulphonylamino) pentylpiperidine derivatives, their preparation and their therapeutic application
BG106534A (en) Oral solution containing galanthamine and a sweetening agent
AU580890B2 (en) P-acylaminobenzamides
IS4733A (is) Ný LH-RH mótlyf, framleiðsla þeirra og notkun, ásamt læknislyfjum sem innihalda samsetningarnar og framleiðsla þeirra

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19990716

Kind code of ref document: A1

Effective date: 19990716